Evolve 4.5-5.0

Evolve 4.5-5.0

The purpose of the study is to confirm the safety and effectiveness of the Synergy 4.50 mm and 5.00 mm drug eluding coronary stent system for the treatment of patients with coronary artery disease in large vessels. This Post Approval study is a cohort associated with the Synergy Megatron post approval study.

Please use this link for further information:

Primary Investigator: Steven Rudick